$PHG News

Royal Philips Receives FDA Approval For Elevate Plus, Bringing AI Toolkits To Its EPIQ Elite And Affiniti Ultrasound Systems

Philips Sets Share Dividend Ratio, To Issue Nearly 20M New Shares

Koninklijke Philips: AI Upside, And Margin Expansion Create An Attractive Entry Point

Teleradiology Research Report 2026: Global Market to Grow at a CAGR of 21.53% During 2025-2031 with Koninklijke Philips, Radiology Partners, and Teleradiology Solutions Leading

Philips (PHG) Reports Q1 Adjusted EPS

Koninklijke Philips N.V. Just Beat EPS By 123%: Here's What Analysts Think Will Happen Next

Philips shareholders approve all proposals at the AGM 2026

Koninklijke Philips N.V. 2026 Q1 - Results - Earnings Call Presentation

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

Philips profits double in first quarter

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Philips Reiterates 2026 Outlook With 3%-4.5% Comparable Sales Growth, 12.5%-13.0% Adjusted EBITA Margin And EUR 1.3B-1.5B Free Cash Flow Target

Koninklijke Philips Q1 Adj. EPS $0.27 Beats $0.23 Estimate, Sales $4.572B Miss $4.600B Estimate

Assessing Philips (ENXTAM:PHIA) Valuation After New CT Clearances And Bridge Plus Occlusion Balloon Launch

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Is It Time To Reassess Philips (ENXTAM:PHIA) After Its Mixed Multi‑Year Share Performance?

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Royal Philips Receives 510(k) Clearance From FDA For Its Rembra Platform Of Scanning Systems, Including Rembra CT, Rembra RT And Areta RT

Royal Philips Receives FDA 510(k) Clearance For Philips Spectral CT Verida System, Bringing Next-Gen, AI-Powered Spectral CT Innovation To US